Pfizer Announces Positive Late Stage Trial of Cancer Treatment
Pfizer shares were rising Thursday morning.

Pfizer Inc. (PFE) shares were slightly higher in morning trading Thursday after the company announced positive results from its late stage trials of prostate cancer treatment candidate Xtandi. 

The trial was conducted in conjunction with Astellas Pharma Inc. (ALPMF) and found that Xtandi, when combined with a standard prostate cancer therapy, improved survival rates relative to just standard prostate treatments on its own. 

There are currently no FDA-approved treatments for patients with non-metastatic castration-resistant prostate cancer. 

More of What's Trending on TheStreet:

More from Stocks

Kohl's Slumps on Tuesday Amid Weak Guidance, Retail Selloff

Kohl's Slumps on Tuesday Amid Weak Guidance, Retail Selloff

Chart of the Day: Is Kohl's a Playable Stock on a Pullback?

Chart of the Day: Is Kohl's a Playable Stock on a Pullback?

Wednesday Wrap-Up: This Market Is Un-Bear-Able

Wednesday Wrap-Up: This Market Is Un-Bear-Able

Federated Investors Stock Is Set to Change Direction

Federated Investors Stock Is Set to Change Direction

Market Movers: Federal Reserve Review

Market Movers: Federal Reserve Review